About ANTIRNA INCORPORATED
AntiRNA is a privately held virology company focused on developing small-molecule antiviral therapeutics, with a current emphasis on treatments for COVID-19. The company's research targets viral RNA methylation processes to create broad-spectrum antiviral agents.
Development of small-molecule antiviral agentsResearch on viral RNA methylation inhibitionFocus on antiviral therapeutics for COVID-19
Is this your company?
Claim ANTIRNA INCORPORATED to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ANTIRNA INCORPORATED & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.